These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3453427)

  • 21. Antagonistic effects of some metabolites and analogues of mianserin on serotonin and alpha 1- and alpha 2-adrenergic receptors in the flexor reflex model in vivo.
    Przegaliński E; Rawłów A; Dohnal-Borak I
    Pol J Pharmacol Pharm; 1986; 38(1):69-75. PubMed ID: 3020532
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The influence of mianserin and danitracen on the disappearance of noradrenaline in the rat brain.
    Klimek V; Mogilnicka E
    Pol J Pharmacol Pharm; 1978; 30(2-3):255-61. PubMed ID: 673929
    [No Abstract]   [Full Text] [Related]  

  • 23. The inability of chronic mianserin to block central alpha 2-adrenoceptors.
    Sugrue MF
    Eur J Pharmacol; 1980 Dec; 68(3):377-80. PubMed ID: 6110547
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The olfactory bulbectomized rat as a model of depression.
    Leonard BE
    Pol J Pharmacol Pharm; 1984; 36(5):561-9. PubMed ID: 6099892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of methylphenidate on the hyperemotional behavior in olfactory bulbectomized mice by using the hole-board test.
    Kamei J; Hirose N; Oka T; Miyata S; Saitoh A; Yamada M
    J Pharmacol Sci; 2007 Feb; 103(2):175-80. PubMed ID: 17299244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relative importance of 3-methoxy-4-hydroxyphenylglycol and 3,4-dihydroxyphenylglycol as norepinephrine metabolites in rat, monkey, and humans.
    Elsworth JD; Roth RH; Redmond DE
    J Neurochem; 1983 Sep; 41(3):786-93. PubMed ID: 6875564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regional distribution and production rate of 3-methoxy-4-hydroxyphenylethyleneglycol sulphate (MHPG-SO4) in rat brain.
    Kohno Y; Tanaka M; Nakagawa R; Toshima N; Nagasaki N
    J Neurochem; 1981 Jan; 36(1):286-9. PubMed ID: 7463053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The olfactory bulbectomized rat as a model of depression: an update.
    Kelly JP; Wrynn AS; Leonard BE
    Pharmacol Ther; 1997; 74(3):299-316. PubMed ID: 9352586
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in amygdaloid afterdischarges and kindling effect following olfactory bulbectomy in the rat.
    Watanabe S; Nakanishi H; Shibata S; Ueki S
    Physiol Behav; 1982 Apr; 28(4):687-92. PubMed ID: 7200621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pharmacological properties of MO-8282, a novel antidepressant].
    Niho T; Ito C; Shibutani Y; Hashizume H; Yamaguchi K
    Nihon Yakurigaku Zasshi; 1986 Oct; 88(4):309-20. PubMed ID: 3792961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The potential therapeutic role of the enantiomers and metabolites of mianserin.
    Pinder RM; Van Delft AM
    Br J Clin Pharmacol; 1983; 15 Suppl 2(Suppl 2):269S-276S. PubMed ID: 6824558
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stereospecificity of behavioural effects of viloxazine in bulbectomized rats does not correlate with its 5-HT-releasing action in vitro.
    Greenwood DT; Kemp JD; Middlemiss DN
    J Pharm Pharmacol; 1982 Jan; 34(1):38-41. PubMed ID: 6174722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The determination of the optimal dose of milnacipran in the olfactory bulbectomized rat model of depression.
    Redmond AM; Kelly JP; Leonard BE
    Pharmacol Biochem Behav; 1999 Apr; 62(4):619-23. PubMed ID: 10208367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in brain catecholamine levels following olfactory bulbectomy and the effect of acute and chronic administration of desipramine in rats.
    Iwasaki K; Fujiwara M; Shibata S; Ueki S
    Pharmacol Biochem Behav; 1986 Jun; 24(6):1715-9. PubMed ID: 3737637
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The involvement of neuropeptide Y in the antimuricide action of noradrenaline injected into the medial amygdala of olfactory bulbectomized rats.
    Kataoka Y; Sakurai Y; Mine K; Yamashita K; Fujiwara M; Niwa M; Ueki S
    Pharmacol Biochem Behav; 1987 Sep; 28(1):101-3. PubMed ID: 3659100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determination of the enantiomers of mianserin, desmethylmianserin, and 8-hydroxymianserin in the plasma and urine of mianserin-treated patients.
    Eap CB; Powell K; Campus-Souche D; Monney C; Baettig D; Taeschner W; Baumann P
    Chirality; 1994; 6(7):555-63. PubMed ID: 7986669
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rat brain norepinephrine metabolism: substantial clearance through 3,4-dihydroxyphenylethyleneglycol formation.
    Li PP; Warsh JJ; Godse DD
    J Neurochem; 1983 Oct; 41(4):1065-71. PubMed ID: 6619846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serotonin receptor sensitivity after acute and chronic treatment with mianserin.
    Blackshear MA; Sanders-Bush E
    J Pharmacol Exp Ther; 1982 May; 221(2):303-8. PubMed ID: 7077527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Behavioural and neurochemical effects of dizocilpine in the olfactory bulbectomized rat model of depression.
    Redmond AM; Kelly JP; Leonard BE
    Pharmacol Biochem Behav; 1997 Oct; 58(2):355-9. PubMed ID: 9300592
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Postnatal development of noradrenaline and 3-methoxy-4-hydroxyphenylethyleneglycol sulphate levels in rat brain regions.
    Kohno Y; Tanaka M; Nakagawa R; Ida Y; Iimori K; Nagasaki N
    J Neurochem; 1982 Sep; 39(3):878-81. PubMed ID: 7097293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.